David A. Roth's Insider Trades & SAST Disclosures

David A. Roth's most recent trade in Syros Pharmaceuticals Inc. was a trade of 12,099 Common Stock done at an average price of $0.2 . Disclosure was reported to the exchange on Nov. 18, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Syros Pharmaceuticals Inc.
David A. Roth Chief Medical Officer Sale of securities on an exchange or to another person at price $ 0.20 per share. 18 Nov 2024 12,099 0 (0%) 0% 0.2 2,382 Common Stock
Syros Pharmaceuticals Inc.
David A. Roth Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Oct 2024 18,875 0 - - Restricted Stock Units
Syros Pharmaceuticals Inc.
David A. Roth Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Oct 2024 18,875 18,875 (0%) 0% - Common Stock
Syros Pharmaceuticals Inc.
David A. Roth Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.09 per share. 31 Oct 2024 6,776 12,099 (0%) 0% 2.1 14,162 Common Stock
Syros Pharmaceuticals Inc.
David A. Roth Chief Medical Officer Sale of securities on an exchange or to another person at price $ 4.95 per share. 03 Apr 2024 10,451 0 (0%) 0% 4.9 51,732 Common Stock
Syros Pharmaceuticals Inc.
David A. Roth Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2024 13,333 15,333 (0%) 0% - Common Stock
Syros Pharmaceuticals Inc.
David A. Roth Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2024 13,333 26,667 - - Restricted Stock Units
Syros Pharmaceuticals Inc.
David A. Roth Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.12 per share. 31 Mar 2024 4,732 10,601 (0%) 0% 5.1 24,228 Common Stock
Syros Pharmaceuticals Inc.
David A. Roth Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2024 2,000 4,000 - - Restricted Stock Units
Syros Pharmaceuticals Inc.
David A. Roth Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2024 2,000 2,000 (0%) 0% - Common Stock
Syros Pharmaceuticals Inc.
David A. Roth Chief Medical Officer Sale of securities on an exchange or to another person at price $ 4.98 per share. 31 Mar 2024 150 10,451 (0%) 0% 5.0 747 Common Stock
Syros Pharmaceuticals Inc.
David A. Roth Chief Medical Officer Sale of securities on an exchange or to another person at price $ 4.95 per share. 12 Dec 2023 6,287 0 (0%) 0% 5.0 31,121 Common Stock
Syros Pharmaceuticals Inc.
A. Roth David Chief Medical Officer Sale of securities on an exchange or to another person at price $ 3.95 per share. 06 Dec 2023 6,287 6,287 (0%) 0% 4.0 24,834 Common Stock
Syros Pharmaceuticals Inc.
David A. Roth Chief Medical Officer Sale of securities on an exchange or to another person at price $ 3.95 per share. 31 Jul 2023 7,348 0 (0%) 0% 4.0 29,025 Common Stock
Syros Pharmaceuticals Inc.
David A. Roth Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2023 2,000 7,971 (0%) 0% - Common Stock
Syros Pharmaceuticals Inc.
David A. Roth Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2023 2,000 6,000 - - Restricted Stock Units
Syros Pharmaceuticals Inc.
David A. Roth Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.58 per share. 31 Mar 2023 623 7,348 (0%) 0% 2.6 1,607 Common Stock
Syros Pharmaceuticals Inc.
David A. Roth Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2023 40,000 40,000 - - Restricted Stock Units
Syros Pharmaceuticals Inc.
David A. Roth Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2022 49,750 49,750 - - Stock Option (right to buy)
Syros Pharmaceuticals Inc.
David A. Roth Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2022 37,750 37,750 - - Restricted Stock Units
Syros Pharmaceuticals Inc.
David A. Roth Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.12 per share. 01 Apr 2022 27,281 59,719 (0%) 0% 1.1 30,555 Common Stock
Syros Pharmaceuticals Inc.
David A. Roth Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 200,000 200,000 - - Restricted Stock Units
Syros Pharmaceuticals Inc.
David A. Roth Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 125,000 125,000 - - Stock Option (right to buy)
Syros Pharmaceuticals Inc.
David A. Roth Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 80,000 80,000 - - Restricted Stock Units
Syros Pharmaceuticals Inc.
David A. Roth Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2021 119,000 119,000 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades